Tumor Lysis Syndrome (definition)

encyclopedia of medical concepts

ψ ψ	Tumor Lysis Syndrome

More information in Books or on

Definition: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.

lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent
See Also Tumor Necrosis Factor-alpha

Other names Tumour Lysis Syndromes; Tumor Lysis Syndromes; Syndromes, Tumour Lysis; Syndromes, Tumor Lysis; Syndrome, Tumour Lysis; Syndrome, Tumor Lysis; Tumour Lysis Syndrome

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link

Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor

We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy